PT-141 10mg (Bremelanotide) is a synthetic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH), supplied as a reference compound for laboratory and in-vitro research use only. Its receptor selectivity is well characterized, which makes it a defined tool for probing central melanocortin signaling.

In cell-culture and preclinical models, PT-141 functions as a potent agonist at melanocortin receptors — primarily MC4R, with reported activity at MC1R and MC3R — engaging centrally expressed melanocortin receptor populations. Its well-mapped receptor profile makes it a frequent point of reference in melanocortin structure–activity work.

Key research areas

  • Melanocortin receptor signaling, with emphasis on MC4R and secondary MC1R/MC3R activity
  • Neuroendocrine pathways and hypothalamic signaling models
  • Receptor-binding and functional (cAMP accumulation) assays across melanocortin receptor subtypes
  • Comparative structure–activity studies across cyclic α-MSH analogs

Specifications

  • Amount: 10mg
  • Form: Lyophilized white powder
  • Compound class: Synthetic heptapeptide α-MSH analog (Bremelanotide)
  • Storage: Refrigerate at 2–8°C
  • Quality: Third-party tested for identity and purity; a Certificate of Analysis is available on request

PT-141 10mg is intended strictly for in-vitro laboratory research. It is not for human or veterinary use and not for diagnostic or therapeutic purposes.